Disc Medicine (IRON) Change in Acquisitions & Divestments (2024 - 2026)

Disc Medicine (IRON) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $114.4 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 3.63% year-over-year to $114.4 million; the TTM figure through Jun 2026 stood at $536.8 million (up 91.3% YoY), while the FY2025 annual figure was $456.2 million, up 381.24% from the prior year.
• Change in Acquisitions & Divestments declined to $114.4 million in Q2 2026 per IRON's latest filing, from $152.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $152.1 million in Q1 2026 and bottomed at $23.0 million in Q3 2024.
• Historically, Change in Acquisitions & Divestments has averaged $102.2 million across 3 years, with a median of $112.4 million in 2025.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 486.96% — and 2026, when it rose 3.63%.
• Disc Medicine's Change in Acquisitions & Divestments stood at $71.8 million in 2024, then soared by 88.58% to $135.4 million in 2025, then fell by 15.54% to $114.4 million in 2026.
• Business Quant data shows IRON's Change in Acquisitions & Divestments at $114.4 million in Q2 2026, $152.1 million in Q1 2026, and $135.4 million in Q4 2025.